Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies
Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial. Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic...
Gespeichert in:
Veröffentlicht in: | Nutrition reviews 2024-07 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | Nutrition reviews |
container_volume | |
creator | Fallah, Melika Karim Dehnavi, Maryam Lotfi, Keyhan Aminianfar, Azadeh Azadbakht, Leila Esmaillzadeh, Ahmad |
description | Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.
Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.
A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.
Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.
A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P |
doi_str_mv | 10.1093/nutrit/nuae077 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3074726240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3074726240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</originalsourceid><addsrcrecordid>eNo9kU-P00AMxUcIxJaFK0c0Rw6bZf4kmYRbSSmstAjUco-cjKMdmmTKeFLUr8anI0sDJ0v2e8-Wf4y9luJWilK_G6cYXJwLoDDmCVtJk-kkLQrzlK2EUGWS56m-Yi-IfgghpCr1c3alizITqcxX7PfW9xCRf3B-gHDAQDd8ad2NEQ54w2G0fOfowH3HNwjxgW-DH_i673kFE-HsqCBY509A7dRD4BtHCLRYKxhbDO_5mu_PFHGA6Fq-w5PDX3_nG0-Y7JCOfiTkXzBCsh6hP5Ojx43fgqcjttGdkFf-wYfI93GyDukle9ZBT_hqqddsv_34vfqc3H_9dFet75NWFiImeaOKPDOptbJJRYMaIFNNZjtTmE50XalaNCV0ubSZVFmWpQry1ArVSKusvmZvL6nH4H9OSLEeHLXY9zCin6jWwqRG5SoVs_T2Im3nmylgVx-Dm796rqWoH2nVF1r1Qms2vFmyp2ZA-1_-D4_-AwlulS8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3074726240</pqid></control><display><type>article</type><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</creator><creatorcontrib>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</creatorcontrib><description>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.
Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.
A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.
Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.
A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P < .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality.
This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings.
PROSPERO registration no. CRD42023401700.</description><identifier>ISSN: 0029-6643</identifier><identifier>ISSN: 1753-4887</identifier><identifier>EISSN: 1753-4887</identifier><identifier>DOI: 10.1093/nutrit/nuae077</identifier><identifier>PMID: 38950416</identifier><language>eng</language><publisher>United States</publisher><ispartof>Nutrition reviews, 2024-07</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</cites><orcidid>0000-0001-6139-9578 ; 0000-0002-0490-8492</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38950416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fallah, Melika</creatorcontrib><creatorcontrib>Karim Dehnavi, Maryam</creatorcontrib><creatorcontrib>Lotfi, Keyhan</creatorcontrib><creatorcontrib>Aminianfar, Azadeh</creatorcontrib><creatorcontrib>Azadbakht, Leila</creatorcontrib><creatorcontrib>Esmaillzadeh, Ahmad</creatorcontrib><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><title>Nutrition reviews</title><addtitle>Nutr Rev</addtitle><description>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.
Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.
A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.
Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.
A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P < .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality.
This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings.
PROSPERO registration no. CRD42023401700.</description><issn>0029-6643</issn><issn>1753-4887</issn><issn>1753-4887</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kU-P00AMxUcIxJaFK0c0Rw6bZf4kmYRbSSmstAjUco-cjKMdmmTKeFLUr8anI0sDJ0v2e8-Wf4y9luJWilK_G6cYXJwLoDDmCVtJk-kkLQrzlK2EUGWS56m-Yi-IfgghpCr1c3alizITqcxX7PfW9xCRf3B-gHDAQDd8ad2NEQ54w2G0fOfowH3HNwjxgW-DH_i673kFE-HsqCBY509A7dRD4BtHCLRYKxhbDO_5mu_PFHGA6Fq-w5PDX3_nG0-Y7JCOfiTkXzBCsh6hP5Ojx43fgqcjttGdkFf-wYfI93GyDukle9ZBT_hqqddsv_34vfqc3H_9dFet75NWFiImeaOKPDOptbJJRYMaIFNNZjtTmE50XalaNCV0ubSZVFmWpQry1ArVSKusvmZvL6nH4H9OSLEeHLXY9zCin6jWwqRG5SoVs_T2Im3nmylgVx-Dm796rqWoH2nVF1r1Qms2vFmyp2ZA-1_-D4_-AwlulS8</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Fallah, Melika</creator><creator>Karim Dehnavi, Maryam</creator><creator>Lotfi, Keyhan</creator><creator>Aminianfar, Azadeh</creator><creator>Azadbakht, Leila</creator><creator>Esmaillzadeh, Ahmad</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6139-9578</orcidid><orcidid>https://orcid.org/0000-0002-0490-8492</orcidid></search><sort><creationdate>20240701</creationdate><title>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</title><author>Fallah, Melika ; Karim Dehnavi, Maryam ; Lotfi, Keyhan ; Aminianfar, Azadeh ; Azadbakht, Leila ; Esmaillzadeh, Ahmad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c180t-6b286574dd1b40be3aa52b5df787f0ff92ce79af61d51255542a64d02b1d2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fallah, Melika</creatorcontrib><creatorcontrib>Karim Dehnavi, Maryam</creatorcontrib><creatorcontrib>Lotfi, Keyhan</creatorcontrib><creatorcontrib>Aminianfar, Azadeh</creatorcontrib><creatorcontrib>Azadbakht, Leila</creatorcontrib><creatorcontrib>Esmaillzadeh, Ahmad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fallah, Melika</au><au>Karim Dehnavi, Maryam</au><au>Lotfi, Keyhan</au><au>Aminianfar, Azadeh</au><au>Azadbakht, Leila</au><au>Esmaillzadeh, Ahmad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies</atitle><jtitle>Nutrition reviews</jtitle><addtitle>Nutr Rev</addtitle><date>2024-07-01</date><risdate>2024</risdate><issn>0029-6643</issn><issn>1753-4887</issn><eissn>1753-4887</eissn><abstract>Existing evidence on the relation between folate intake and biomarkers with mortality risk is controversial.
Previous cohort studies were examined regarding folate intake and biomarkers in relation to risk of all-cause, cardiovascular disease- (CVD), and cancer-related mortality through a systematic review and meta-analysis.
A systematic search was performed of the PubMed, Scopus, and ISI Web of Science databases up to July 2023.
Prospective cohort studies examining the association of folate biomarkers (in serum, plasma, red blood cells) and intake with risk of all-cause, CVD-, and cancer-related mortality were considered. A random-effects model was applied to combine study-specific risk estimates. Dose-response relations were assessed by 1-stage weighted mixed-effects meta-analysis.
A total of 25 cohorts with 423 304 participants, 36 558 all-cause, 12 662 CVD-, and 2426 cancer-related deaths were included. No significant association was observed between the highest levels of folate biomarkers and all-cause mortality risk (hazard ratio [HR], 0.91; 95% CI, 0.77-1.06; n = 17; I2 = 89.4%; P < .001), CVD-related mortality risk (HR, 0.97; 95% CI, 0.87-1.06; n = 11; I2 = 0.0%; P = .57), and cancer-related mortality risk (HR, 0.85; 95% CI, 0.69-1.05; n = 6; I2 = 57.8%; P = .04) compared with the lowest. Furthermore, each 10 nmol/L increase was marginally related to a 12% reduced all-cause mortality risk but not to CVD- and cancer-related mortality risk. A significant inverse association was found between highest intake of dietary folate and the lowest, and risk of all-cause (HR, 0.87; 95% CI, 0.78-0.96; n = 3; I2 = 63.6%; P = .06) and CVD (HR, 0.77; 95% CI, 0.57-0.93; n = 4; I2 = 80.2%; P = .002) mortality.
This meta-analysis revealed a significant inverse relation between dietary folate intake and risk of all-cause and CVD mortality. Such an association was not found in the case of folate biomarkers. Further prospective studies are warranted to confirm these findings.
PROSPERO registration no. CRD42023401700.</abstract><cop>United States</cop><pmid>38950416</pmid><doi>10.1093/nutrit/nuae077</doi><orcidid>https://orcid.org/0000-0001-6139-9578</orcidid><orcidid>https://orcid.org/0000-0002-0490-8492</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0029-6643 |
ispartof | Nutrition reviews, 2024-07 |
issn | 0029-6643 1753-4887 1753-4887 |
language | eng |
recordid | cdi_proquest_miscellaneous_3074726240 |
source | Oxford University Press Journals All Titles (1996-Current) |
title | Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A32%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Folate%20Biomarkers,%20Folate%20Intake,%20and%20Risk%20of%20Death%20From%20All%20Causes,%20Cardiovascular%20Disease,%20and%20Cancer:%20A%20Systematic%20Review%20and%20Dose-Response%20Meta-Analysis%20of%20Prospective%20Cohort%20Studies&rft.jtitle=Nutrition%20reviews&rft.au=Fallah,%20Melika&rft.date=2024-07-01&rft.issn=0029-6643&rft.eissn=1753-4887&rft_id=info:doi/10.1093/nutrit/nuae077&rft_dat=%3Cproquest_cross%3E3074726240%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3074726240&rft_id=info:pmid/38950416&rfr_iscdi=true |